Add Yahoo as a preferred source to see more of our stories on Google. Moderna's headquarters in Cambridge, Mass., in 2024. (dam Glanzman / Bloomberg via Getty Images) (Adam Glanzman) The Food and Drug ...

Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject ...

There’s been quite a bit of news about COVID-19 booster shots lately, and it’s been more confusing than reassuring. Public health officials don’t agree on whether everyone needs a booster yet, and in ...

The state Department of Health has shortened the waiting period for Rhode Islanders to receive a booster shot of the Pfizer COVID-19 vaccine. Instead of waiting six months after their first two Pfizer ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F.